Date:2/18/2009

s the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today.

    Contact:
    SpectraScience, Inc.
    Jim Hitchin, Chief Executive Officer
    (858) 847-0200 x 201
   http://www.spectrascience.com

    Hayden Communications
    Investor Relations
    Todd Pitcher
    (858)-518-1387

'/>"/>

SOURCE SpectraScience, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine news :

1. New Local TV Ad Campaign To Educate St. Louis Women About Cervical Cancer Prevention and HPV Testing
2. New Local TV Ad Campaign To Educate Memphis Women About Cervical Cancer Prevention and HPV Testing
3. HPV18 DNA levels are not prognostic for precancerous cervical lesions
4. Photos: Despite Widespread Awareness, Most Women Still Dont Feel at Risk for Cervical Cancer
5. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
6. Multiple Screening Strategy Boosts Cervical Cancer Detection
7. The PA Breast Cancer Coalition Urges You to Donate Your State Income Tax Refund to Breast and Cervical Cancer Research
8. Department of Health Recognizes January As Cervical Health Awareness Month
9. Fears of promiscuity pose barrier to cervical cancer vaccinations
10. Male circumcision may decrease risk of HPV infection and cervical cancer
11. Cervical Cancer Vaccine Well Tolerated